CG MED EQUIP.
838810
BEOKA
870199
Shenzhen Bromake New Material
301387
4
Zhejiang Hongchang Electrical Technology
301008
5
Wuhan Lincontrol Automotive Electronics Co., Ltd.
688667
CN Stock MarketDetailed Quotes
300159 Xinjiang Machinery Research Institute
- 1.78
- +0.02+1.14%
Market Closed Apr 30 15:00 CST
2.67BMarket Cap-8.90P/E (TTM)
1.80High1.74Low360.06KlotVolume1.76Open1.76Pre Close63.83MTurnover2.45%Turnover RatioLossP/E (Static)1.50BShares4.6552wk High-8.36P/B2.62BFloat Cap1.4752wk Low2.11Limit Up1.47BShs Float32.38Historical High1.41Limit Down3.41%Amplitude1.47Historical Low--Dividend TTM1.77Avg Price169.76KlotAsk--Div YieldTTM100Lot Size179.87KlotBid
Xinjiang Machinery Research Institute Key Stats
All
YOY
| (Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 3.93%32.47M | -44.16%664.92M | -44.81%462.12M | -68.83%105.02M | -49.17%31.24M | -44.46%1.19B | -42.61%837.39M | -39.53%336.9M | -56.70%61.46M | 57.28%2.14B |
| Operating revenue | 3.93%32.47M | -44.16%664.92M | -44.81%462.12M | -68.83%105.02M | -49.17%31.24M | -44.46%1.19B | -42.61%837.39M | -39.53%336.9M | -56.70%61.46M | 57.28%2.14B |
| Other operating revenue | ---- | -48.93%15.3M | ---- | -55.53%6.65M | ---- | -14.93%29.97M | ---- | -55.07%14.95M | ---- | 92.00%35.23M |
| Total operating cost | 0.07%98.75M | -29.04%913.26M | -31.43%655.19M | -40.95%259.09M | -22.60%98.68M | -35.05%1.29B | -31.31%955.51M | -28.61%438.77M | -24.56%127.49M | 30.17%1.98B |
| Operating cost | 14.89%32.12M | -38.87%547.86M | -36.72%387.75M | -57.65%105.3M | -39.92%27.96M | -41.29%896.22M | -39.34%612.77M | -40.90%248.63M | -50.35%46.54M | 41.00%1.53B |
| Operating tax surcharges | -3.28%1.95M | -15.59%11.64M | -14.58%7.84M | 79.11%5.59M | 22.25%2.02M | -30.95%13.79M | -0.00%9.18M | -54.54%3.12M | -4.99%1.65M | 22.75%19.97M |
| Operating expense | -29.12%3.1M | -17.67%26.67M | -47.07%34.68M | -47.76%11.57M | -40.14%4.37M | -24.07%32.4M | -23.25%65.52M | -4.28%22.14M | 55.93%7.3M | 23.74%42.67M |
| Administration expense | -13.67%25.85M | -11.74%145.27M | -21.72%100.68M | -20.35%62.05M | -20.35%29.94M | -0.50%164.59M | -0.54%128.62M | 8.08%77.9M | 28.26%37.59M | -14.05%165.41M |
| Financial expense | -2.37%29.24M | 4.55%136.13M | 7.10%89.58M | 21.90%60.26M | 22.53%29.95M | -3.28%130.21M | -6.27%83.64M | -18.18%49.44M | -23.50%24.44M | 4.99%134.63M |
| -Interest expense (Financial expense) | -3.34%30.38M | 1.35%141.76M | 4.70%94.05M | 23.16%64.13M | 19.10%31.43M | 0.46%139.88M | -0.90%89.83M | -14.51%52.07M | -18.26%26.39M | 7.21%139.23M |
| -Interest Income (Financial expense) | 52.95%-1.17M | 36.62%-6.23M | 12.16%-5.94M | -36.19%-3.92M | -14.87%-2.49M | -81.17%-9.83M | -80.56%-6.76M | -146.54%-2.88M | -5,313.31%-2.17M | -175.97%-5.42M |
| Research and development | 46.10%6.5M | -8.07%45.7M | -37.85%34.66M | -61.82%14.34M | -55.39%4.45M | -46.06%49.71M | -17.53%55.77M | 19.59%37.55M | 31.42%9.98M | 35.40%92.15M |
| Credit Impairment Loss | 78.75%16.85M | -101.50%-24.86M | -106.44%-936.67K | 526.55%6.25M | 44.59%9.42M | 28.37%-12.34M | 684.83%14.55M | -92.30%997.13K | 59.32%6.52M | -634.56%-17.23M |
| Asset Impairment Loss | 83.85%-1.72M | -76.59%-55.86M | 15.72%5.27M | -56.20%2.37M | -204.71%-10.67M | 55.03%-31.63M | 109.76%4.56M | 116.62%5.41M | 72.58%-3.5M | 34.96%-70.34M |
| Other net revenue | 5,021.96%16.35M | -434.06%-55.29M | -69.68%10.29M | -11.09%13.91M | -96.33%319.2K | 85.37%-10.35M | 180.70%33.94M | 192.74%15.65M | 241.39%8.69M | 27.84%-70.76M |
| Invest income | -4.87%-601.5K | 113.07%650.1K | 84.05%-702.52K | 113.23%424.54K | 23.44%-573.56K | -194.32%-4.98M | -256.65%-4.41M | -65.98%-3.21M | -16.75%-749.15K | -138.33%-1.69M |
| -Including: Investment income associates | -4.87%-421.05K | 49.38%-2.58M | 77.06%-491.76K | 117.05%297.18K | ---401.49K | -117.84%-5.1M | -111.45%-2.14M | 12.52%-1.74M | ---- | -25.29%-2.34M |
| Asset deal income | -1,992.18%-1.53M | -68.59%1.74M | -588.64%-1.34M | 150.40%81.08K | --81.08K | 36.42%5.55M | 78.59%-194.85K | 539.78%32.38K | ---- | 152.77%4.07M |
| Other revenue | 63.12%3.36M | -30.27%23.04M | -58.83%8M | -61.44%4.79M | -67.93%2.06M | 129.08%33.04M | 110.53%19.44M | 163.59%12.41M | 85.39%6.43M | 41.91%14.42M |
| Operating profit | 25.61%-49.93M | -184.89%-303.63M | -117.15%-182.79M | -62.56%-140.16M | -17.06%-67.12M | -216.41%-106.58M | -422.97%-84.18M | -15.93%-86.22M | -72.78%-57.33M | 135.60%91.56M |
| Add:Non operating Income | 1,219.17%71.94K | -99.33%26.95K | -90.46%383.17K | -96.61%135.7K | -94.96%5.45K | 541.82%4.03M | 430.70%4.02M | 743.89%4M | 158.89%108.13K | -72.96%627.41K |
| Less:Non operating expense | -61.41%234.92K | 46.99%16.68M | -61.68%3.25M | -65.31%1.88M | -82.49%608.8K | 140.86%11.35M | 809.06%8.49M | 552.35%5.43M | 964.03%3.48M | -56.98%4.71M |
| Total profit | 26.03%-50.09M | -181.20%-320.29M | -109.43%-185.66M | -61.90%-141.91M | -11.56%-67.72M | -230.22%-113.9M | -442.46%-88.65M | -17.28%-87.65M | -81.37%-60.7M | 132.90%87.47M |
| Less:Income tax cost | -94.78%66.64K | -43.73%19.86M | -72.16%5.46M | -56.33%2.98M | -54.43%1.28M | 61.31%35.29M | 13.54%19.62M | 92.63%6.82M | 627.23%2.8M | 24.87%21.88M |
| Net profit | 27.30%-50.16M | -127.99%-340.15M | -76.53%-191.12M | -53.36%-144.89M | -8.65%-69M | -327.46%-149.19M | -1,357.38%-108.26M | -20.69%-94.47M | -87.58%-63.5M | 123.15%65.59M |
| Net profit from continuing operation | 27.30%-50.16M | -141.67%-340.15M | -78.95%-191.12M | -55.78%-144.89M | -8.65%-69M | -313.76%-140.75M | -1,305.25%-106.8M | -19.20%-93.01M | -87.58%-63.5M | 122.64%65.84M |
| Net income from discontinuing operating | --0 | ---- | ---- | --0 | --0 | -3,267.88%-8.45M | -484.31%-1.47M | -484.31%-1.47M | ---- | -103.34%-250.8K |
| Less:Minority Profit | 33.41%-2.37M | -34.96%-21.58M | -9.43%-13.09M | -5.38%-8.14M | 4.69%-3.56M | -45.68%-15.99M | -48.93%-11.97M | -2.79%-7.73M | -114.12%-3.74M | 56.85%-10.98M |
| Net profit of parent company owners | 26.97%-47.79M | -139.15%-318.57M | -84.86%-178.02M | -57.63%-136.75M | -9.48%-65.43M | -273.97%-133.21M | -678.57%-96.3M | -22.59%-86.75M | -86.13%-59.77M | 129.68%76.57M |
| Earning per share | ||||||||||
| Basic earning per share | 27.23%-0.0318 | -142.06%-0.2181 | -81.65%-0.1188 | -56.70%-0.0912 | -8.98%-0.0437 | -275.29%-0.0901 | -683.93%-0.0654 | -22.53%-0.0582 | -86.51%-0.0401 | 129.69%0.0514 |
| Diluted earning per share | 27.23%-0.0318 | -142.06%-0.2181 | -81.65%-0.1188 | -56.70%-0.0912 | -8.98%-0.0437 | -275.29%-0.0901 | -683.93%-0.0654 | -22.53%-0.0582 | -86.51%-0.0401 | 129.69%0.0514 |
| Other composite income | ||||||||||
| Total composite income | 27.30%-50.16M | -127.99%-340.15M | -76.53%-191.12M | -53.36%-144.89M | -8.65%-69M | -327.46%-149.19M | -1,357.38%-108.26M | -20.69%-94.47M | -87.58%-63.5M | 123.15%65.59M |
| Total composite income of parent company owners | 26.97%-47.79M | -139.15%-318.57M | -84.86%-178.02M | -57.63%-136.75M | -9.48%-65.43M | -273.97%-133.21M | -678.57%-96.3M | -22.59%-86.75M | -86.13%-59.77M | 129.68%76.57M |
| Total composite income of minority owners | 33.41%-2.37M | -34.96%-21.58M | -9.43%-13.09M | -5.38%-8.14M | 4.69%-3.56M | -45.68%-15.99M | -48.93%-11.97M | -2.79%-7.73M | -114.12%-3.74M | 56.85%-10.98M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | Unqualified opinion | -- | -- | -- | -- | -- | -- | -- | -- |
| Auditor | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Daxin Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.